Catalyst Pharmaceuticals (CPRX) Competitor Comparison
We are evaluating the key criteria listed to compare Catalyst Pharmaceuticals (CPRX) against its competitors in the Biotechnology industry.
Market Capitalization
91 / 368Gross Profits
38 / 278Total Revenue
33 / 300EBITDA
16 / 337Free Cashflow
327 / 352Quick Ratio
262 / 357Earnings per Share
19 / 359Dividend yield
0 / 6Total Cash
200 / 358Performance 3 years
22 / 368Performance 5 years
22 / 368Performance 10 years
13 / 368Linearity 3 years
339 / 368Linearity 5 years
368 / 368Linearity 10 years
355 / 368Total Rank
78 / 368Dividend Rank
79 / 368Valuation Rank
194 / 368Piotroski Rank
26 / 368Muliplier Rank
307 / 368Market Capitalization - CPRX ranking 91 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.